Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Type:
Application
Filed:
November 4, 2010
Publication date:
February 24, 2011
Applicant:
PARION SCIENCES, Inc.
Inventors:
Michael R. JOHNSON, Bruce F. Molino, Jianzhong Zhang, Bruce Sargent
Abstract: The present invention relates to group of butylphenyl-pyrazinoylguanidine compounds useful as sodium channel blockers. The compounds may be used to promote promoting hydration of mucosal surfaces.
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Type:
Application
Filed:
June 11, 2007
Publication date:
January 13, 2011
Applicant:
PARION SCIENCES, Inc.
Inventors:
Michael Ross Johnson, Andrew J. Hirsh, Richard C. Boucher, Jianzhong Zhang
Abstract: The invention relates to substituted pyrazinoylguanidine compounds. These compounds are useful as sodium channel blockers, and may be effective in treating a variety of conditions including chronic bronchitis and cystic fibrosis.
Type:
Grant
Filed:
March 17, 2008
Date of Patent:
January 11, 2011
Assignee:
Parion Sciences, Inc.
Inventors:
Michael R. Johnson, Bruce F. Molino, Jianzhong Zhang, Bruce Sargent
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Type:
Application
Filed:
September 7, 2010
Publication date:
January 6, 2011
Applicant:
PARION SCIENCES, Inc.
Inventors:
Michael R. JOHNSON, Bruce F. Molino, Bruce Sargent, Jianzhong Zhang
Abstract: The present invention relates to pyrazinoylguanidine compounds represented by the formula: where the structural variables are defined herein. The compounds are useful as sodium channel blockers.
Abstract: Provided are methods of increasing hydration of mucosal surfaces by topically administering sodium channel blocking pyrazinoylguanidine compounds.
Abstract: The present invention relates to group of pyrazinoylguanidine compounds useful as sodium channel blockers. The compounds may be used to promote promoting hydration of mucosal surfaces.
Type:
Grant
Filed:
August 3, 2005
Date of Patent:
October 5, 2010
Assignee:
Parion Sciences, Inc.
Inventors:
Michael R. Johnson, Bruce F. Molino, Bruce Sargent, Jianzhong Zhang
Abstract: Prophylactic treatment methods are provided for protection of individuals and/or populations against infection from airborne pathogens. In particular, prophylactic treatment methods are provided including administering a sodium channel blocker or pharmaceutically acceptable salts thereof to one or more members of a population at risk of exposure to or already exposed to one or more airborne pathogens, either from natural sources or from intentional release of pathogens into the environment.
Abstract: The present invention relates to sodium channel blockers. The present invention also relates to a variety of methods of treatment using the sodium channel blockers.
Abstract: A device for administering two or more therapeutic agents simultaneously, comprising two or more nebulizers and a single connector linking the nebulizers to a nebulizer mouthpiece. Also provided is a method of administering two or more therapeutic agents simultaneously, comprising administering the therapeutic agents simultaneously with the device of the present invention to a subject in need thereof.
Type:
Application
Filed:
July 13, 2009
Publication date:
March 25, 2010
Applicant:
PARION SCIENCES, Inc.
Inventors:
Richard C. BOUCHER, Michael R. Johnson, Keith A. Johnson, William R. Thelin
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Abstract: Polyaromatic sodium channel blockers represented by the formula: are provided where the structural variables are defined herein. The invention also includes a variety of compositions, combinations and methods of treatment using these inventive sodium channel blockers.
Abstract: The invention described herein is directed to method of treating chronic obstructive pulmonary disease, comprising administering an effective amount of an osmolyte by at least one nasal cannula to a subject in need thereof. Also provided is a nasal cannula system for delivering an osmolyte, comprising a nebulizer and tubing having two ends, where the first end of the tubing is connected to the nebulizer and the second end of the tubing is tapered to fit in the nostril of a subject.
Type:
Application
Filed:
October 10, 2008
Publication date:
April 23, 2009
Applicant:
PARION SCIENCES, Inc.
Inventors:
Richard C. BOUCHER, Michael Ross Johnson
Abstract: The present invention relates to methods and compositions for treating diseases ameliorated by increased mucociliary clearance and mucosal hydration by administering an effective amount of a sodium channel blocker as defined herein and an osmolyte to a subject to a subject in need of increased mucociliary clearance and mucosal hydration.
Type:
Application
Filed:
September 7, 2007
Publication date:
March 26, 2009
Applicant:
PARION SCIENCES, INC.
Inventors:
Michael Ross Johnson, Richard C. Boucher, Andrew J. Hirsh
Abstract: The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Abstract: The present invention relates to use of a compound represented by formula (I): in which at least one of R3 and R4 is a group represented by formula (A): where the structural variables are as defined herein. The compounds are useful for blocking sodium channels and treating a variety of conditions.
Abstract: The present invention relates to compounds represented by formula (I): where the structural variables are as defined herein. The compounds are useful for promoting hydration of mucosal surfaces.
Type:
Application
Filed:
July 11, 2008
Publication date:
January 15, 2009
Applicant:
PARION SCIENCES, Inc.
Inventors:
Michael R. Johnson, Bruce Molino, Jianzhong Zhang, Bruce Sargent